FDA Approves Lilly Liver Cancer Drug

Posted: Updated:
INDIANAPOLIS -

The U.S. Food and Drug Administration has given another approval for a drug from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The approval for Cyramza is for the treatment of patients with hepatocellular carcinoma, the most common form of liver cancer.

The approval is the fifth for Cyramza and the FDA has also removed the boxed warning from the drug's labeling. The treatment, which is administered through an injection, is given to patients who have reached a particular biomarker and have been treated with another drug, sorafenib. 

"This approval of CYRAMZA is an important step forward in the treatment of advanced hepatocellular carcinoma," said Andrew Zhu, professor of medicine at Harvard Medical School and principal investigator of the REACH-2 trial, the results of which led to the approval. "While there have been some recent advances, there are still limited treatment options for people with this type of cancer and – until now – there was no treatment option specifically indicated for patients with increased alpha-fetoprotein concentrations. These patients can have more aggressive disease and a poorer prognosis with increased angiogenesis."

Lilly says HCC is the fourth-leading cause of cancer related deaths worldwide. You can learn more about the approval by clicking here.

  • Perspectives

    • Baby Boomers Are Impacting the Building Industry

      There are currently 78 million baby boomers in the U.S., making up 25% of the population and controlling 67% ($28 trillion) of the country’s wealth, according to the Living In Place Institute. AARP says 90% of people surveyed want to remain as long as possible in their homes. The majority of those 65 and older remodel their home to make it safer and accessible. In fact, 45% of all remodeling work is being done for people over the age of 65. With this amount of data supporting...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Hub & Spoke Aims to Fuel 'Purpose and Passion'

      The co-founder of a $16 million mixed-use development in Fishers says the project aims to have the biggest social impact possible. Officials broke ground Tuesday on Hub & Spoke, which will include a design center, coworking space and makerspace when completed. David Decker says the project is the first of its kind in the nation and seeks to help people find their purpose and passion and tie that into their vocation. In an interview with Inside INdiana Business Reporter...

    • (Photo Courtesy: Roche Diagnostics)

      Roche VP on List of Influential Women Executives

      An executive with Roche Diagnostics has joined an exclusive list of prominent and influential women, including Oprah Winfrey and Serena Williams.  Cindy Carlisle, Vice President of Human Resources at Roche Indy, was named to Savoy Magazine’s 2019 Most Influential Women in Corporate America. 

    • The facility could be build within the River Ridge Commerce Center.

      Jeffersonville Being Considered for CBD Plant

      California-based Layn USA could soon establish operations in southern Indiana. One Southern Indiana, the economic development organization and chamber of commerce for Clark and Floyd counties, says the company has signed a purchase and sales agreement with the River Ridge Development Authority for a proposed $52 million CBD manufacturing facility. The project, the company says, would have the capacity to process a minimum of 5,000 tons of hemp biomass each year. As part of the...

    • Rendering courtesy of Two EEs Winery

      Two-EE's Winery to Adopt New Age Policy

      Two-EE's Winery in Huntington has announced it will adopt a new age policy begining in August. Our partners at WPTA-TV report the winery will no longer allow people aged under 21 to visit the establishment due to ongoing problems with unsupervised or misbehaving children. 

    • New Mixed-Use Development Planned for Fishers

      A new mixed-use development is coming to Fishers. Thompson Thrift Retail Group has announced the development of The Station, an office building that is part of an overall project that includes a 150-room hotel, a future retail pad along 116th Street and nearly 40 3-story townhomes.